TFC

Prezzo Truist Financial Corp

Closed
TFC
$47,83
+$0,19(+0,39%)

*Data last updated: 2026-04-08 00:42 (UTC+8)

As of 2026-04-08 00:42, Truist Financial Corp (TFC) is priced at $47,83, with a total market cap of $59,74B, a P/E ratio of 11,75, and a dividend yield of 4,34%. Today, the stock price fluctuated between $47,30 and $48,18. The current price is 1,12% above the day's low and 0,72% below the day's high, with a trading volume of 12,34M. Over the past 52 weeks, TFC has traded between $44,27 to $48,18, and the current price is -0,72% away from the 52-week high.

TFC Key Stats

Yesterday's Close$47,64
Market Cap$59,74B
Volume12,34M
P/E Ratio11,75
Dividend Yield (TTM)4,34%
Dividend Amount$0,52
Diluted EPS (TTM)4,18
Net Income (FY)$5,30B
Revenue (FY)$30,43B
Earnings Date2027-01-20
EPS Estimate1,24
Revenue Estimate$5,49B
Shares Outstanding1,25B
Beta (1Y)0.869
Ex-Dividend Date2026-02-13
Dividend Payment Date2026-03-02

About TFC

Truist Financial Corporation, a holding company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through three segments: Consumer Banking and Wealth, Corporate and Commercial Banking, and Insurance Holdings. Its deposit products include noninterest-bearing checking, interest-bearing checking, savings, and money market deposit accounts, as well as certificates of deposit and individual retirement accounts. The company also provides funding; asset management; automobile lending; bankcard lending; consumer finance; home equity and mortgage lending; insurance, such as property and casualty, life, health, employee benefits, workers compensation and professional liability, surety coverage, title, and other insurance products; investment brokerage; mobile/online banking; and payment, lease financing, small business lending, and wealth management/private banking services. In addition, it offers association, capital market, institutional trust, insurance premium and commercial finance, international banking, leasing, merchant, commercial deposit and treasury, government finance, commercial middle market lending, small business and student lending, floor plan and commercial mortgage lending, mortgage warehouse lending, private equity investment, real estate lending, and supply chain financing services. Further, the company provides corporate and investment banking, retail and wholesale brokerage, securities underwriting, and investment advisory services. As of December 31, 2021, the company operated through 2,517 banking offices. The company was formerly known as BB&T Corporation and changed its name to Truist Financial Corporation in December 2019. Truist Financial Corporation was founded in 1872 and is headquartered in Charlotte, North Carolina.
SectorFinancial Services
IndustryBanks - Regional
CEOWilliam Henry Rogers Jr.
HeadquartersCharlotte,NC,US
Official Websitehttps://www.truist.com

Truist Financial Corp (TFC) FAQ

What's the stock price of Truist Financial Corp (TFC) today?

x
Truist Financial Corp (TFC) is currently trading at $47,83, with a 24h change of +0,39%. The 52-week trading range is $44,27–$48,18.

What are the 52-week high and low prices for Truist Financial Corp (TFC)?

x

What is the price-to-earnings (P/E) ratio of Truist Financial Corp (TFC)? What does it indicate?

x

What is the market cap of Truist Financial Corp (TFC)?

x

What is the most recent quarterly earnings per share (EPS) for Truist Financial Corp (TFC)?

x

Should you buy or sell Truist Financial Corp (TFC) now?

x

What factors can affect the stock price of Truist Financial Corp (TFC)?

x

How to buy Truist Financial Corp (TFC) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Truist Financial Corp (TFC)

SelfRugger

SelfRugger

11 ore fa
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) ======================================================================== Muhammad Ali Khalid Tue, February 17, 2026 at 3:00 AM GMT+9 2 min read In this article: CNTA TFC Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the **17 biotechnology stocks with more than 50% upside**. On January 29, Danielle Brill from Truist Financial raised her price target on Centessa Pharmaceuticals (NASDAQ:CNTA) from $33 to $38 and assigned a Buy rating to the stock. Her rating came after Truist Financial updated its projections following a thorough reassessment of the current data regarding the orexin-2 receptor agonist class. M. A. Arkhipov/Shutterstock.com On January 16, Biren Amin from Piper Sandler maintained an Overweight rating on Centessa Pharmaceuticals (NASDAQ:CNTA). He forecasted a $38 price target for the stock, which implied a 57% upside potential. Amin highlighted two major catalysts expected this quarter. These include the planned initiation of Phase 3 trials for ORX750 across NT1, NT2, and IH, along with additional findings from the CRYSTAL-1 Phase 2 study. The analyst is optimistic about idiopathic hypersomnia as it may represent a larger and potentially underappreciated market opportunity. Centessa Pharmaceuticals (NASDAQ:CNTA) is involved in the discovery and development of transformative medicines for neurological and neurodegenerative diseases. The company operates under an asset-centric Research and Development model, with a portfolio of subsidiaries that support specialized research programs. These individual programs are treated as separate entities to ensure highly efficient, data-driven decision-making. While we acknowledge the potential of CNTA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the **best short-term AI stock**. **READ NEXT: ****15 Most Promising Mid-Cap Healthcare Stocks Under $50**** and ****11 Most Promising Small-Cap Industrial Stocks Under $50****.** Disclosure: None. This article is originally published at **Insider Monkey**. Terms and Privacy Policy Privacy Dashboard More Info
1
0
0
0
ForkLibertarian

ForkLibertarian

04-05 05:30
Trump’s Tariff Tactics ---------------------- After a long weekend for US investors, attention is back on tariffs, with US President Donald Trump threatening European allies with 10% levies over their refusal to support his desire to take over Greenland. Trump’s threats, and the possibility of European nations having to retaliate, rattled markets on the other side of the Atlantic Monday. “Higher tariffs from the US and Europe are a destructive way forward,” says Robert Bergqvist, Senior Economist at SEB. The Greenland dispute adds to the geopolitical noise investors are having to navigate at the start of 2026. At the same time, investors are still waiting for the Supreme Court to weigh in on whether Trump’s use of tariffs under the International Emergency Economic Powers Act is legal. “The new tariffs presumably would rely on IEEPA authority, which is what the Supreme Court is reviewing,” says Preston Caldwell, Morningstar’s senior US economist. “If the Supreme Court strikes down IEEPA tariffs, the Trump administration will have to rely on statutory authority, which historically has entailed lengthy process and paperwork. Hence, it would become likely much harder to slap countrywide tariffs on and off for arbitrary reasons.” Speaking of the Supreme Court, Wednesday will bring oral arguments over whether Trump can remove Federal Reserve Governor Lisa Cook from the central bank. This at a time when investors have grown increasingly wary about Trump’s efforts to influence monetary policy and erode the Fed’s independence. Big Bank Bumps -------------- Fourth-quarter earnings season is now in full swing, and as investors await earnings from Big Tech in coming weeks, big banks have been in the spotlight. It was a bumpy start, as JPMorgan JPM and BankAmerica BAC stocks took a hit, while Citigroup C shares seesawed. But it wasn’t necessarily earnings news that was driving the market. Again, it was news out of the White House as Trump proposed a 10% cap on credit card interest rates. As we wrote last week, bank executives and analysts panned the idea, saying it would limit credit availability to lower quality borrowers and hurt profits. As for the key takeaways from the actual earnings reports, the outlook looks pretty decent according to Sean Dunlop, a director at Morningstar who follows the big banks. Here’s what Dunlop has to say: > * **2026 is setting up to be another solid year for banks if the current backdrop holds.** Asset prices remain high. Interest rates are set to decline modestly, with Morningstar senior US economist Preston Caldwell forecasting two rate cuts in his December outlook, in line with CME estimates. And we expect still-solid 4.4% nominal gross domestic product growth … which in conjunction with a labor market that is weaker (but not dramatically so) looks like a decent setup for banks. > * **Consumer health looks solid.** Credit and debit card spending was up 6%-7% in nominal terms basically across the board for the banks, and consumer health, proxied by charge-offs, was very strong. Barring significant deterioration in the labor market, we’re looking at an environment where sentiment and spending continue to diverge sharply. > * **Things might really be better at Citi.** The bank reported sharply stronger results across segments, with particular improvement in wealth management and the retail bank, but every segment saw returns improve by more than 2.5 percentage points. > > Key Earnings This Week ---------------------- For many investors, the big earnings news is still a week off, when the likes of Microsoft MSFT, Tesla TSLA, and Apple AAPL report. In the meantime, the focus will be on regional banks and other key names. **Regional Banks:** Throughout the week, regional banks will report. That includes Zions ZION and US Bancorp USB reporting Tuesday, and Truist TFC on Wednesday. Morningstar equity analyst Maoyuan Chen has this to say about what she will be watching: > * **Consumer health looks solid.** The money center banks that have already reported have shown credit and debit card spending up 6%-7% in nominal terms across the board. Credit costs were mostly stable. > * **Regional banks’ net interest income will face some headwinds in 2026** from two or three rate cuts from the Fed. How much growth the regional banks can achieve will depend on balance sheet growth. We currently forecast around 3%-4% growth, but we could see bank lending growing faster from more commercial real estate loan growth (a headwind in the past three years) or higher commercial lending growth from a pickup in middle-market M&A deal activity. > * **2025 was a busy year for bank acquisitions**, including deal announcements from PNC-FirstBank, Fifth Third-Comerica, Huntington-Cadence, and Huntington-Veritex. We will be watching out for execution updates on these deals and other regional banks’ appetite for inorganic opportunities. > > **Airlines:** United Airlines UAL reports Wednesday. “With Delta having already reported and showing some softness among the leisure market in the fourth quarter, I’ll be watching how that played out for the other airlines and certainly listening for how their bookings are stacking up so far this year,” says Nicolas Owens, equity analyst at Morningstar. “The industry has returned to a low single-digit growth mode after several big rebound years postpandemic.” **GE Aerospace:** Thursday will bring fourth-quarter earnings from GE Aerospace GE, which is up some 77% over the past year, thanks to a rally that began in the spring of 2025. For Owens, “the biggest question is just how their supply chain is holding up, as they have so much demand to meet from Airbus for new engines and from existing engine operators for parts.” ### What’s Happening In the Markets This Week Stock Market Rotation or Another Head Fake? ------------------------------------------- As we alluded to earlier this month, stock market strategists have predicted 10 of the last two rotations out of tech stocks. Will those forecasts be wrong yet again? So far, 2026 has started off in rotation mode for stocks. It’s visible at the sector level, with tech stocks performing the worst while basic materials are out in front. The rotation can also be seen on a market capitalization basis, as small caps have jumped ahead of large caps. It’s even visible by style, with value outpacing growth. Will this early rotation continue? We’ll know more as earnings season progresses. For now, check out our story on what the early 2026 rotation is looking like.
0
0
0
0